Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

2.
4.

Onset and progression of experimental bioprosthetic heart valve calcification.

Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M.

Lab Invest. 1985 May;52(5):523-32.

PMID:
3990244
5.

Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes.

Levy RJ, Schoen FJ, Howard SL.

Am J Cardiol. 1983 Sep 1;52(5):629-31.

PMID:
6604449
6.

Biochemical differences between dystrophic calcification of cross-linked collagen implants and mineralization during bone induction.

Nimni ME, Bernick S, Cheung DT, Ertl DC, Nishimoto SK, Paule WJ, Salka C, Strates BS.

Calcif Tissue Int. 1988 May;42(5):313-20.

PMID:
3135100
7.

Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue.

Meuris B, Ozaki S, Herijgers P, Verbeken E, Flameng W.

Semin Thorac Cardiovasc Surg. 2001 Oct;13(4 Suppl 1):99-105.

PMID:
11805957
8.
10.

Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.

Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ.

Circulation. 1997 Jan 21;95(2):479-88.

11.
12.

Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system.

Fishbein MC, Levy RJ, Ferrans VJ, Dearden LC, Nashef A, Goodman AP, Carpentier A.

J Thorac Cardiovasc Surg. 1982 Apr;83(4):602-9.

PMID:
7062771
13.
14.

Epoxy compounds as a new cross-linking agent for porcine aortic leaflets: subcutaneous implant studies in rats.

Imamura E, Sawatani O, Koyanagi H, Noishiki Y, Miyata T.

J Card Surg. 1989 Mar;4(1):50-7.

PMID:
2519982
15.

Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep.

Ogle MF, Kelly SJ, Bianco RW, Levy RJ.

Ann Thorac Surg. 2003 Apr;75(4):1267-73.

PMID:
12683574
16.

Osteopontin is associated with bioprosthetic heart valve calcification in humans.

Shen M, Marie P, Farge D, Carpentier S, De Pollak C, Hott M, Chen L, Martinet B, Carpentier A.

C R Acad Sci III. 1997 Jan;320(1):49-57.

PMID:
9099263
17.

No-react detoxification process: a superior anticalcification method for bioprostheses.

Abolhoda A, Yu S, Oyarzun JR, Allen KR, McCormick JR, Han S, Kemp FW, Bogden JD, Lu Q, Gabbay S.

Ann Thorac Surg. 1996 Dec;62(6):1724-30.

PMID:
8957377
18.

Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.

Grabenwöger M, Sider J, Fitzal F, Zelenka C, Windberger U, Grimm M, Moritz A, Böck P, Wolner E.

Ann Thorac Surg. 1996 Sep;62(3):772-7.

PMID:
8784007
19.

Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies.

Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ.

J Biomed Mater Res. 1993 Dec;27(12):1477-84.

PMID:
8113234
20.

Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions.

Gong G, Seifter E, Lyman WD, Factor SM, Blau S, Frater RW.

J Heart Valve Dis. 1993 Nov;2(6):684-93.

PMID:
7719511
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk